Myeloma, Refractory, Relapse, Stem cell transplantation, Thalidomide resistance
dx.doi.org/10.3816/CLML.2010.n.020, hdl.handle.net/1765/83402
Clinical Lymphoma, Myeloma and Leukemia
Erasmus MC: University Medical Center Rotterdam

Kneppers, E, Lokhorst, H.M, Eeltink, C.M, Huls, G, Kersten, M.J, Koedam, J, … Zweegman, S. (2010). Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a dutch compassionate use program. Clinical Lymphoma, Myeloma and Leukemia, 10(2), 138–143. doi:10.3816/CLML.2010.n.020